A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair/replacement for severe mitral stenosis

Annals of Cardiac Anaesthesia

Volumn 16, Issue 1, 2013, Pages 11-15

  Gandham, Ravikumar ^a   Syamasundar, Ayya ^a   Ravulapalli, Harish ^a   Karthekeyan, Ranjith ^a   Vakamudi, Mahesh ^a   Kodalli, Rajeshkumar B ^a   Nandipati, Sushma ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Cardiac index; Dobutamine; Hemodynamics; Levosimendan; Systemic vascular resistance index

Indexed keywords

ADRENALIN; DOBUTAMINE; LACTIC ACID; LEVOSIMENDAN; NORADRENALIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART RATE; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTEMIC VASCULAR RESISTANCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; VASODILATATION;

ADULT; ARTERIAL PRESSURE; CARDIAC OUTPUT; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CENTRAL VENOUS PRESSURE; DOBUTAMINE; DOUBLE-BLIND METHOD; FEMALE; HEART ARREST, INDUCED; HEART RATE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYDRAZONES; HYPOTHERMIA, INDUCED; LACTIC ACID; MALE; MITRAL VALVE; MITRAL VALVE STENOSIS; PROSPECTIVE STUDIES; PYRIDAZINES; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 84872856975     PISSN: 09719784     EISSN: 09745181     Source Type: Journal    
DOI: 10.4103/0971-9784.105363     Document Type: Article

References (17)

1. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15:1261-9.
2. Doyle AR, Dhir AK, Moors AH, Latimer RD. Treatment of perioperative low cardiac output syndrome. Ann Thorac Surg 1995;59:S3-11.
3. Tamargo J, López-Sendón J. Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure. Rev Esp Cardiol 2004;57:447-64.
4. Cody RJ. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? I. Introduction. J Am Coll Cardiol 1988;12:559-61.
5. Chatterjee K, Wolfe CL, deMarco T. Nonglicoside inotropes in congestive heart failure: Are they beneficial or harmful? Cardiol Clin 1994;12:63-72.
6. Laffey JG, Boyland JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Anesthesiology 2002;97:215-52.
7. Lilleberg J, Nieminen MS, Akkila J, Heikkilae L, Kuitunen A, Lehtonen L. Effects of a new calcium sensitizer, levosimendan, on the haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19:660-8.
8. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 1998;34:219-28.
9. Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther 2004;42:204-11.
10. Delange Segura L, Jerez Anera M, Carmona Aurioles J, Rodríguez Fernández S. Levosimendan as inotropic support during coronary surgery with extracorporeal circulation in a patient with severely depressed ventricular function. Rev Esp Anestesiol Reanim 2003;50:423-4.
11. Fernández AL, García-Bengochea JB, Ledo R, Vega M, Amaro A, Álvarez J, et al. ally invasive surgical implantation of left ventricular epicardial leads for ventricular resynchronization using video-assisted thoracoscopy. Rev Esp Cardiol 2004;57:313-9.
12. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Rev Esp Cardiol 2005;58:389-429.
13. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A. Comparision of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001;15:306-15.
14. Álvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006;59:338-45.
15. Kivikko M, Lehtonen L. Levosimendan: A new inodilatory drug for the treatment of decompensated heart failure. Curr Pharm Des 2005;11:435-55.
16. Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003;107:81-6.
17. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002;360:196-202.